2019
We here present a case of neonatal skin damage due to application of methylene blue (MB) on a newborn's skin. MB use should be completely eliminated in neonatal intensive care units and nurseries, because of three potentially dangerous adverse effects of this compound: (1) It may act as an irritant when applied topically on intact skin, leading to skin reddening up to deep full-thickness eschars; (2) Is possesses photosensitizing properties, and may produce skin reddening followed by blisters and peeling after UV phototherapy; (3) It is a proscribed substance in patients affected by glucose-6-phosphate dehydrogenase deficiency, a condition not easily detected in the very first days of life.
Article
Accepted version
English
Neonatologia; Dermatologia; Pediatria intensiva; Neonatología; Dermatología; Cuidados intensivos neonatales; Neonatology; Dermatology; Intensive care, neonatal
2
ACT Publishing Group Limited
Journal of Respiratory Research
5; 1
Silecchia, Valeria; Valerio, Enrico; Merazzi, Daniele [et al.]. Why methylene blue should be blacklisted in neonatology. Journal of Respiratory Research, 2019. 5(1), p. 1-2. Disponible en: <http://www.ghrnet.org/index.php/jdr/article/view/2731/3037>. Fecha de acceso: 23 jun. 2020. DOI:10.17554/j.issn.2412-2424.2019.05.46-5
© 2018 The Author(s). Published by ACT Publishing Group Ltd. All rights reserved. This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Articles de recerca [2420]